Promising combo for aplastic anemia trial pulled before start
NCT ID NCT07522996
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to test whether adding enarodustat to cyclosporine helps people with a type of aplastic anemia who need regular blood transfusions. The trial was withdrawn before enrolling any participants, so no results are available. It would have compared the combination to cyclosporine alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Enarodustat and cyclosporine
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.